Empagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus at High Cardiovascular Risk

被引：0
作者：
Inzucchi, Silvio E. [1 ]
Wanner, Christoph [2 ]
Lachin, John M. [3 ]
Fitchett, David [4 ]
Bluhmki, Erich [5 ]
Hantel, Stefan [5 ]
Mattheus, Michaela [6 ]
Devins, Theresa [7 ]
Johansen, Odd Erik [8 ]
Woerle, Hans Juergen [8 ]
Broedl, Uli C. [9 ]
Zinman, Bernard [10 ,11 ,12 ]
机构：
[1] Yale Univ, Sch Med, Endocrinol Sect, New Haven, CT USA
[2] Wurzburg Univ Clin, Div Nephrol, Dept Med, Wurzburg, Germany
[3] George Washington Univ, Biostat Unit, Rockville, MD USA
[4] St Michaels Hosp, Div Cardiol, Toronto, ON M5B 1W8, Canada
[5] Boehringer Ingelheim Pharma GmbH & Co KG, Global Biometr & Datamanagement, Biberach, Germany
[6] Boehringer Ingelheim Pharma GmbH & Co KG, Global Biometr & Datamanagement, Ingelheim, Germany
[7] Boehringer Ingelheim Pharmaceut Inc, Clin Operat, Ridgefield, CT USA
[8] Boehringer Ingelheim Norway KS, Therapeut Area Metab, Asker, Norway
[9] Boehringer Ingelheim Pharma GmbH & Co KG, Therapeut Area Metab, Ingelheim, Germany
[10] Mt Sinai Hosp, Lunenfeld Tanenbaum Rsch Inst, Toronto, ON M5G 1X5, Canada
[11] Mt Sinai Hosp, Div Endocrinol, Toronto, ON M5G 1X5, Canada
[12] Univ Toronto, Toronto, ON, Canada
来源：
CIRCULATION | 2015年 / 132卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
20238
引用
收藏
页码：2271 / 2271
页数：1
相关论文
共 50 条
  • [41] Reducing Global Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus
    Gavin, James R., III
    [J]. JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION, 2008, 108 (05): : S14 - S19
  • [42] Osteprotegerin as cardiovascular risk marker in patients with type 2 diabetes mellitus
    Rozas-Moreno, P.
    Munoz-Torres, M.
    Alonso, G.
    Fernandez-Garcia, D.
    Luque-Fernandez, I.
    Sebastian-Ochoa, A.
    Escobar-Jimenez, F.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S271 - S271
  • [43] Cardiovascular risk of sitagliptin in treating patients with type 2 diabetes mellitus
    Zeng, De-kang
    Xiao, Qian
    Li, Fa-qi
    Tang, Yu-zhi
    Jia, Chao-li
    Tang, Xue-wen
    [J]. BIOSCIENCE REPORTS, 2019, 39
  • [44] Assessment of Cardiovascular Risk Factors in Patients With Type 2 Diabetes Mellitus
    Ramona, Dragut R.
    Rusu, Emilia
    Radulian, Gabriela
    Parpala, Cristina
    Popescu, Horatiu
    Nan, Raluca
    [J]. DIABETES, 2012, 61 : A562 - A563
  • [45] Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME® trial
    Fitchett, David
    Zinman, Bernard
    Wanner, Christoph
    Lachin, John M.
    Hantel, Stefan
    Salsali, Afshin
    Johansen, Odd Erik
    Woerle, Hans J.
    Broedl, Uli C.
    Inzucchi, Silvio E.
    Aizenberg, D.
    Ulla, M.
    Waitman, J.
    De Loredo, L.
    Farias, J.
    Fideleff, H.
    Lagrutta, M.
    Maldonado, N.
    Colombo, H.
    Ferre Pacora, F.
    Wasserman, A.
    Maffei, L.
    Lehman, R.
    Selvanayagam, J.
    d'Emden, M.
    Fasching, P.
    Paulweber, B.
    Toplak, H.
    Luger, A.
    Drexel, H.
    Prager, R.
    Schnack, C.
    Schernthaner, G.
    Fliesser-Goerzer, E.
    Kaser, S.
    Scheen, A.
    Van Gaal, L.
    Hollanders, G.
    Kockaerts, Y.
    Capiau, L.
    Chachati, A.
    Persu, A.
    Hermans, M.
    Vantroyen, D.
    Vercammen, C.
    Van de Borne, P.
    Mathieu, C.
    Benhalima, K.
    Lienart, F.
    Mortelmans, J.
    [J]. EUROPEAN HEART JOURNAL, 2016, 37 (19) : 1526 - 1534
  • [46] Thiazolidinedione and cardiovascular risk in type 2 diabetes mellitus
    Yenny
    [J]. UNIVERSA MEDICINA, 2008, 27 (04) : 183 - 193
  • [47] Cardiovascular risk assessment in type 2 diabetes mellitus
    Ebaa Al-Ozairi
    R. Jan-Willem Middelbeek
    Edward S. Horton
    [J]. Current Diabetes Reports, 2006, 6 (5)
  • [48] Type 2 diabetes mellitus is not a cardiovascular risk equivalent
    Saely, CH
    Marte, T
    Aczel, S
    Langer, P
    Koch, L
    Schmid, F
    Drexel, H
    [J]. DIABETES, 2005, 54 : A182 - A183
  • [49] Cardiovascular risk in the spectrum of type 2 diabetes mellitus
    Ahmed, Intekhab
    Goldstein, Barry J.
    [J]. MOUNT SINAI JOURNAL OF MEDICINE, 2006, 73 (05): : 759 - 768
  • [50] Response by Zinman et al to Letter Regarding Article, "Empagliflozin and Cerebrovascular Events in Patients With Type 2 Diabetes Mellitus at High Cardiovascular Risk"
    Zinman, Bernard
    Inzucchi, Silvio E.
    Diener, Hans Christoph
    [J]. STROKE, 2017, 48 (09) : E256 - E257
12345